212 related articles for article (PubMed ID: 15825079)
1. Therapeutic effects of rectal administration of basic fibroblast growth factor on experimental murine colitis.
Matsuura M; Okazaki K; Nishio A; Nakase H; Tamaki H; Uchida K; Nishi T; Asada M; Kawasaki K; Fukui T; Yoshizawa H; Ohashi S; Inoue S; Kawanami C; Hiai H; Tabata Y; Chiba T
Gastroenterology; 2005 Apr; 128(4):975-86. PubMed ID: 15825079
[TBL] [Abstract][Full Text] [Related]
2. Therapeutic effects of rectal administration of muscovite on experimental colitis in rats.
Chen Y; Chen Y; Liu WL; Zhou TH; Cai JT; Du Q; Wang LJ; Wu JG; Si JM
J Gastroenterol Hepatol; 2009 May; 24(5):912-9. PubMed ID: 19220658
[TBL] [Abstract][Full Text] [Related]
3. Adiponectin deficiency protects mice from chemically induced colonic inflammation.
Fayad R; Pini M; Sennello JA; Cabay RJ; Chan L; Xu A; Fantuzzi G
Gastroenterology; 2007 Feb; 132(2):601-14. PubMed ID: 17258715
[TBL] [Abstract][Full Text] [Related]
4. Mucosa repair mechanisms of Tong-Xie-Yao-Fang mediated by CRH-R2 in murine, dextran sulfate sodium-induced colitis.
Gong SS; Fan YH; Wang SY; Han QQ; Lv B; Xu Y; Chen X; He YE
World J Gastroenterol; 2018 Apr; 24(16):1766-1778. PubMed ID: 29713130
[TBL] [Abstract][Full Text] [Related]
5. Role of metallothionein in murine experimental colitis.
Tsuji T; Naito Y; Takagi T; Kugai M; Yoriki H; Horie R; Fukui A; Mizushima K; Hirai Y; Katada K; Kamada K; Uchiyama K; Handa O; Konishi H; Yagi N; Ichikawa H; Yanagisawa R; Suzuki JS; Takano H; Satoh M; Yoshikawa T
Int J Mol Med; 2013 May; 31(5):1037-46. PubMed ID: 23467591
[TBL] [Abstract][Full Text] [Related]
6. R-spondin1, a novel intestinotrophic mitogen, ameliorates experimental colitis in mice.
Zhao J; de Vera J; Narushima S; Beck EX; Palencia S; Shinkawa P; Kim KA; Liu Y; Levy MD; Berg DJ; Abo A; Funk WD
Gastroenterology; 2007 Apr; 132(4):1331-43. PubMed ID: 17408649
[TBL] [Abstract][Full Text] [Related]
7. Mesenchymal stem cells alleviate TNBS-induced colitis by modulating inflammatory and autoimmune responses.
Chen QQ; Yan L; Wang CZ; Wang WH; Shi H; Su BB; Zeng QH; Du HT; Wan J
World J Gastroenterol; 2013 Aug; 19(29):4702-17. PubMed ID: 23922467
[TBL] [Abstract][Full Text] [Related]
8. Curcumin prevents and ameliorates trinitrobenzene sulfonic acid-induced colitis in mice.
Sugimoto K; Hanai H; Tozawa K; Aoshi T; Uchijima M; Nagata T; Koide Y
Gastroenterology; 2002 Dec; 123(6):1912-22. PubMed ID: 12454848
[TBL] [Abstract][Full Text] [Related]
9. Repeated enemas with hepatocyte growth factor selectively stimulate epithelial cell proliferation of injured mucosa in rats with experimental colitis.
Setoyama H; Ido A; Numata M; Moriuchi A; Yamaji N; Tamai T; Funakawa K; Fujita H; Sakiyama T; Uto H; Oketani M; Tsubouchi H
Life Sci; 2011 Aug; 89(7-8):269-75. PubMed ID: 21763320
[TBL] [Abstract][Full Text] [Related]
10. Protective Actions of Epithelial 5-Hydroxytryptamine 4 Receptors in Normal and Inflamed Colon.
Spohn SN; Bianco F; Scott RB; Keenan CM; Linton AA; O'Neill CH; Bonora E; Dicay M; Lavoie B; Wilcox RL; MacNaughton WK; De Giorgio R; Sharkey KA; Mawe GM
Gastroenterology; 2016 Nov; 151(5):933-944.e3. PubMed ID: 27480173
[TBL] [Abstract][Full Text] [Related]
11. A novel NF-κB inhibitor, dehydroxymethylepoxyquinomicin, ameliorates inflammatory colonic injury in mice.
Funakoshi T; Yamashita K; Ichikawa N; Fukai M; Suzuki T; Goto R; Oura T; Kobayashi N; Katsurada T; Ichihara S; Ozaki M; Umezawa K; Todo S
J Crohns Colitis; 2012 Mar; 6(2):215-25. PubMed ID: 22325176
[TBL] [Abstract][Full Text] [Related]
12. Amelioration of dextran sulfate sodium-induced colitis by anti-macrophage migration inhibitory factor antibody in mice.
Ohkawara T; Nishihira J; Takeda H; Hige S; Kato M; Sugiyama T; Iwanaga T; Nakamura H; Mizue Y; Asaka M
Gastroenterology; 2002 Jul; 123(1):256-70. PubMed ID: 12105854
[TBL] [Abstract][Full Text] [Related]
13. DA-6034, a derivative of flavonoid, prevents and ameliorates dextran sulfate sodium-induced colitis and inhibits colon carcinogenesis.
Nam SY; Kim JS; Kim JM; Lee JY; Kim N; Jung HC; Song IS
Exp Biol Med (Maywood); 2008 Feb; 233(2):180-91. PubMed ID: 18222973
[TBL] [Abstract][Full Text] [Related]
14. Polyphosphate, an active molecule derived from probiotic Lactobacillus brevis, improves the fibrosis in murine colitis.
Kashima S; Fujiya M; Konishi H; Ueno N; Inaba Y; Moriichi K; Tanabe H; Ikuta K; Ohtake T; Kohgo Y
Transl Res; 2015 Aug; 166(2):163-75. PubMed ID: 25766132
[TBL] [Abstract][Full Text] [Related]
15. Intestinal anti-inflammatory activity of apigenin K in two rat colitis models induced by trinitrobenzenesulfonic acid and dextran sulphate sodium.
Mascaraque C; González R; Suárez MD; Zarzuelo A; Sánchez de Medina F; Martínez-Augustin O
Br J Nutr; 2015 Feb; 113(4):618-26. PubMed ID: 25654996
[TBL] [Abstract][Full Text] [Related]
16. Zhikang Capsule ameliorates dextran sodium sulfate-induced colitis by inhibition of inflammation, apoptosis, oxidative stress and MyD88-dependent TLR4 signaling pathway.
Fei L; Xu K
J Ethnopharmacol; 2016 Nov; 192():236-247. PubMed ID: 27452656
[TBL] [Abstract][Full Text] [Related]
17. Novel anti-inflammatory agent 3-[(dodecylthiocarbonyl)-methyl]-glutarimide ameliorates murine models of inflammatory bowel disease.
Ichikawa N; Yamashita K; Funakoshi T; Ichihara S; Fukai M; Ogura M; Kobayashi N; Zaitsu M; Yoshida T; Shibasaki S; Koshizuka Y; Tsunetoshi Y; Sato M; Einama T; Ozaki M; Umezawa K; Suzuki T; Todo S
Inflamm Res; 2016 Mar; 65(3):245-60. PubMed ID: 26683259
[TBL] [Abstract][Full Text] [Related]
18. Muc2-deficient mice spontaneously develop colitis, indicating that MUC2 is critical for colonic protection.
Van der Sluis M; De Koning BA; De Bruijn AC; Velcich A; Meijerink JP; Van Goudoever JB; Büller HA; Dekker J; Van Seuningen I; Renes IB; Einerhand AW
Gastroenterology; 2006 Jul; 131(1):117-29. PubMed ID: 16831596
[TBL] [Abstract][Full Text] [Related]
19. Characterisation of colonic dysplasia-like epithelial atypia in murine colitis.
Randall-Demllo S; Fernando R; Brain T; Sohal SS; Cook AL; Guven N; Kunde D; Spring K; Eri R
World J Gastroenterol; 2016 Oct; 22(37):8334-8348. PubMed ID: 27729740
[TBL] [Abstract][Full Text] [Related]
20. Chitosan oligosaccharide as potential therapy of inflammatory bowel disease: therapeutic efficacy and possible mechanisms of action.
Yousef M; Pichyangkura R; Soodvilai S; Chatsudthipong V; Muanprasat C
Pharmacol Res; 2012 Jul; 66(1):66-79. PubMed ID: 22475725
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
